Ronald G. Hall II

Ronald G. Hall II is an Associate Professor in the Pharmacy Practice department at Texas Tech University Health Sciences Center School of Pharmacy in Dallas, Texas. He has been with the institution since 2002, initially serving as an Assistant Professor from 2002-2009 before being promoted to his current position as Associate Professor.

His educational background includes:

• Master of Science in Clinical Science (MSCS) from University of Texas Southwestern Medical Center (2006-2009)
• Doctor of Pharmacy (PharmD) from St. Louis College of Pharmacy (1999-2000)
• Bachelor of Science in Pharmacy (BS) from St. Louis College of Pharmacy (1994-1999)

Dr. Hall's research primarily focuses on pharmacokinetics, dose optimization, and the impact of obesity on drug therapy. His work spans antimicrobial therapy, pharmacotherapy for special populations, and clinical pharmacy practice. He has made significant contributions to understanding how body size affects drug dosing and efficacy, particularly in antimicrobial and antifungal treatments.

His publication record shows a strong trend toward research on obesity's impact on drug pharmacokinetics, antimicrobial stewardship, and personalized dosing strategies. He frequently collaborates with researchers across multiple institutions, with a particular emphasis on clinical outcomes research and evidence-based pharmacy practice.

Dr. Hall serves as a peer reviewer for numerous prestigious journals including Advances in Therapy, BMC Infectious Diseases, EBioMedicine, and several antimicrobial and clinical pharmacology journals.

His scholarly activities demonstrate a strong commitment to advancing clinical pharmacy practice through research, education, and mentorship. He has contributed significantly to understanding dosing considerations for special populations, particularly those with obesity, and has helped shape evidence-based practices in antimicrobial therapy.

Dr. Hall is actively involved in pharmacy education and has published on topics related to faculty development and residency training, demonstrating his commitment to the next generation of pharmacists.